CORT - コ―セプト・セラピュ―ティクス (Corcept Therapeutics Incorporated)


   Why Is Corcept (CORT) Down 8.9% Since Last Earnings Report?  2019/12/07 16:31:13 Zacks Investment Research
Corcept (CORT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
   Corcept (CORT) Earnings Beat in Q3, Korlym Boosts Sales  2019/11/08 09:31:00 Zacks Investment Research
Corcept (CORT) rides high on both earnings and revenue beat in the third quarter.
   Corcept Therapeutics Incorporated : Announces Third quarter 2019 Financial Results and provides corporate update | MarketScreener  2019/11/07 21:35:42 MarketScreener
PDF Version MENLO PARK, Calif., Nov. 07, 2019 -- Corcept Therapeutics Incorporated , a commercial-stage company engaged in the discovery and development of drugs to treat… | November 7, 2019
   Analysts Estimate Corcept Therapeutics (CORT) to Report a Decline in Earnings: What to Look Out for  2019/10/31 14:33:36 Zacks Investment Research
Corcept (CORT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   Why Corcept (CORT) is Poised to Beat Earnings Estimates Again  2019/10/14 14:10:20 Zacks Investment Research
Corcept (CORT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.